Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive rwandan women

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Anastos, Kathryn ^a   Hoover, Donald R ^b   Burk, Robert D ^a   Cajigas, Antonio ^a   Shi, Qiuhu ^c   Singh, Diljeet K ^d   Cohen, Mardge H ^e   Mutimura, Eugene ^f   Sturgis, Charles ^g   Banzhaf, William C ^h   Castle, Philip E ⁱ  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e Jr Hospital of Cook County   (United States)

^f Women's Equity in Access to Care and Treatment   (Rwanda)

^g Providence Regional Medical Center Everett   (United States)

^h UNIVERSITY OF CHICAGO   (United States)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CARCINOGENICITY; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALARIA; OBSERVATIONAL STUDY; PREGNANCY; RISK FACTOR; RWANDA; SEXUAL BEHAVIOR; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINAL LAVAGE; CROSS-SECTIONAL STUDY; MIDDLE AGED; PRECANCER; UTERINE CERVIX TUMOR;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; PRECANCEROUS CONDITIONS; RISK FACTORS; RWANDA; UTERINE CERVICAL NEOPLASMS;

EID: 78149421508     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013525     Document Type: Article

References (26)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1): 12-19.
2. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6): 518-27.
3. Wright TC, Jr., Schiffman M (2003) Adding a test for human papillomavirus DNA to cervical-cancer screening. N Engl J Med 348(6): 489-90.
4. Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM, et al. (2007) A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 195(11): 1582-9.
5. Ho GYF, Bierman R, Beardsley L, CJ Chang, Burk RD (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl. J Med 338: 423-428.
6. Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Hildesheim A, et al. (2008) Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 100(7): 513-7.
7. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, et al. (2008) Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis. Am J Epidemiol.
8. McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, et al. (2008) Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 9(5): 425-34.
9. Castellsague X, Munoz N (2003) Chapter 3: Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31: 20-8.
10. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370(9581): 59-67.
11. Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, et al. (2003) Human papillomavirus type 16 and immune status in human immunodeficiency virusseropositive women. J Natl Cancer Inst 95(14): 1062-71.
12. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, et al. (2005) Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 97(8): 577-86.
13. Singh DK, Anastos K, Hoover DR, Burk RD, Shi Q, et al. (2009) Human papillomavirus infection and cervical cytology in HIV-infected and HIVuninfected Rwandan women. J Infect Dis 199: 1851-61.
14. Castle PE, Stoler MH, Solomon D, Schiffman M (2007) The Relationship of Community Biopsy-Diagnosed Cervical Intraepithelial Neoplasia Grade 2 to the Quality Control Pathology-Reviewed Diagnoses:An ALTS Report. Am J Clin Pathol 127(5): 805-15.
15. Castle PE, Schiffman M, Wheeler CM, Solomon D (2009) Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2. Obstet Gynecol 113(1): 18-25.
16. Stoler MH, Schiffman M (2001) Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUSLSIL Triage Study. JAMA 285(11): 1500-5.
17. Carreon JD, Sherman ME, Guillen D, Solomon D, Herrero R, et al. (2007) CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol 26(4): 441-6.
18. Castle PE, Schiffman M, Gravitt PE, Kendall H, Fishman S, et al. (2002) Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol 68(3): 417-23.
19. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, et al. (2009) A review of human carcinogens-Part B: biological agents. Lancet Oncol 10(4): 321-2.
20. Castle PE, Cox JT, Jeronimo J, Solomon D, Wheeler CM, et al. (2008) An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS). Obstet Gynecol 111(4): 847-56.
21. Clifford GM, Franceschi S (2009) Cancer Risk in HIV-infected persons: influence of CD4 count. Future Oncol 5: 669-678.
22. Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman Tong TC, et al. (2008) for the Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators. Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992-2003. Ann Intern Med 148: 728-736.
23. Dal Maso L, Polesel J, Serraino D, Lise M, Piselli P, et al. (2009) Pattern of cancer risk in persons with AIDS in Italy in the HAART era. British Journal of Cancer 100: 840-847.
24. Pretorius RG, Zhang WH, Belinson JL, Huang MN, Wu LY, et al. (2004) Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 191(2): 430-4.
25. Castle PE, Schiffman M, Bratti MC, Hildesheim A, Herrero R, et al. (2004) A population based study of vaginal human papillomavirus infection in hysterectomized women. J Infect Dis 190(3): 458-67.
26. Castle PE, Jeronimo J, Schiffman M, Herrero R, Rodriguez AC, et al. (2006) Age related changes of the cervix influence human papillomavirus type distribution. Cancer Res 66(2): 1218-24.